Lymphoma Research Foundation Funds 27 New Grants Supporting the Next Generation of Lymphoma Scientists
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants New York, NY…
Research News
Updates from the 2022 American Society of Hematology Annual Meeting
Updates from the 2022 American Society of Hematology Annual Meeting The Lymphoma Research Foundation (LRF)…
ASH 2022: Primary Central Nervous System Lymphoma Survival Improved with Consolidation Therapy
ASH 2022: Primary Central Nervous System Lymphoma Survival Improved with Consolidation Therapy Consolidation with either…
ASH 2022: Addition of Lenalidomide to Rituximab Therapy is Associated with Improved Survival in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
ASH 2022: Addition of Lenalidomide to Rituximab Therapy is Associated with Improved Survival in Relapsed/Refractory…
ASH 2022: Updated Index Improves Prognostication for Survival in Advanced-Stage Hodgkin Lymphoma
ASH 2022: Updated Index Improves Prognostication for Survival in Advanced-Stage Hodgkin Lymphoma Models that have…
ASH 2022: Durable Responses Observed with Mosunetuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma
ASH 2022: Durable Responses Observed with Mosunetuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma In research presented…
ASH 2022: Quality of Life Improves Quickly in Survivors of Aggressive Lymphomas
ASH 2022: Quality of Life Improves Quickly in Survivors of Aggressive Lymphomas Lymphomas are a…
Where Are They Now? Deborah Stephens, DO
Where Are They Now? Deborah Stephens, DO When did you become interested in the study…
A Multi-Layered View to Lymphoma Research
A Multi-Layered View to Lymphoma Research Some people are born to be scientists, and Eric…
Where Are They Now? Paolo Strati, MD
Where Are They Now? Paolo Strati, MD When did you become interested in the study…
Stay informed with news, alerts and other resources.
